# Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

> **NCT02458768** · PHASE4 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 112 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** IVF-M HP Inj.
- **DRUG:** Menopur® Inj.

## Key facts

- **NCT ID:** NCT02458768
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2016-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458768, "Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02458768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*